Literature DB >> 28817781

Availability and variation of publicly reported prescription drug prices.

Jeffrey T Kullgren1, Joel E Segel, Timothy A Peterson, A Mark Fendrick, Simone Singh.   

Abstract

OBJECTIVES: To examine how often retail prices for prescription drugs are available on state public reporting websites, the variability of these reported prices, and zip code characteristics associated with greater price variation. STUDY
DESIGN: Searches of state government-operated websites in Michigan, Missouri, New York, and Pennsylvania for retail prices for Advair Diskus (250/50 fluticasone propionate/salmeterol), Lyrica (pregabalin 50 mg), Nasonex (mometasone 50 mcg nasal spray), Spiriva (tiotropium 18 mcg cp-handihaler), Zetia (ezetimibe 10 mg), atorvastatin 20 mg, and metoprolol 50 mg.
METHODS: Data were collected for a 25% random sample of 1330 zip codes. For zip codes with at least 1 pharmacy, we used χ2 tests to compare how often prices were reported. For zip codes with at least 2 reported prices, we used Kruskal-Wallis tests to compare the median difference between the highest and lowest prices and a generalized linear model to identify zip code characteristics associated with greater price variation.
RESULTS: Price availability varied significantly (P <.001) across states and drugs, ranging from 52% for metoprolol in Michigan to 1% for atorvastatin in Michigan. Price variation also varied significantly (P <.001) across states and drugs, ranging from a median of $159 for atorvastatin in Pennsylvania to a median of $24 for Nasonex in Missouri. The mean price variation was $52 greater (P <.001) for densely populated zip codes and $60 greater (P <.001) for zip codes with mostly nonwhite residents.
CONCLUSIONS: Publicly reported information on state prescription drug price websites is often deficient. When prices are reported, there can be significant variation in the prices of prescriptions, which could translate into substantial savings for consumers who pay out-of-pocket for prescription drugs.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28817781

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  3 in total

1.  Helping Consumers Make High-Value Health Care Choices: The Devil Is in the Details.

Authors:  Jeffrey T Kullgren
Journal:  Health Serv Res       Date:  2018-04-16       Impact factor: 3.402

2.  Do Cost Limitations of Extended Prophylaxis After Surgery Apply to Ulcerative Colitis Patients?

Authors:  Ira L Leeds; Joseph K Canner; Sandra R DiBrito; Bashar Safar
Journal:  Dis Colon Rectum       Date:  2022-05-01       Impact factor: 4.585

3.  Trends and determinants of retail prescription drug costs.

Authors:  Ben Teasdale; Amanda Nguyen; Jeroen van Meijgaard; Kevin A Schulman
Journal:  Health Serv Res       Date:  2022-03-24       Impact factor: 3.734

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.